#United States #New York #Class Action #The Gross Law Firm #Replimune Group

Important Announcement for Replimune Group Shareholders

The Gross Law Firm recently issued a significant notice regarding a class action lawsuit involving Replimune Group, Inc. (NASDAQ: REPL). This announcement particularly targets shareholders who procured shares during a specified class period. Individuals are encouraged to act promptly and reach out to the firm to explore their entitlements. The deadline for potential lead plaintiff appointments is set for September 22, 2025.

The class period encompasses transactions made between November 22, 2024, and July 21, 2025. The allegations suggest that during this window, the defendants made materially false or misleading statements about the company's prospects. The core of the claims rests on two significant points:
1. The defendants were accused of largely overstating the potential success of a clinical trial known as the IGNYTE trial, despite being cognizant of substantial issues that could adversely impact its results. As a direct consequence, the FDA deemed this trial to be both inadequate and poorly controlled.
2. These exaggerated claims led to the dissemination of misleading information regarding Replimune's overall business operations and future prospects, which lacked any reasonable basis.

Given the potential implications of the outcomes from this lawsuit, affected shareholders are urged to register for participation without delay. Doing so guarantees enrollment in a portfolio monitoring system, which will keep participants updated about the proceedings throughout the case lifecycle.

What Should Shareholders Do Next?

After registering as a shareholder that purchased REPL shares during the mentioned timeframe, you will be integrated into the monitoring software to receive ongoing progress updates. It's crucial to note that registering to participate in the lawsuit carries no cost or obligation. The upcoming deadline to consider seeking a lead plaintiff role approaches on September 22, 2025.

Why Choose The Gross Law Firm?

The Gross Law Firm stands as a leader in the class action legal space. Their mission is centered around protecting investors' rights who have been affected by deceitful and illegal business practices. With a commitment to ensuring corporations engage in responsible business operations and true corporate citizenship, they strive for recovery on behalf of those impacted by fraudulent statements that manipulate stock prices artificially.

If you are a shareholder affected by Replimune Group's alleged misleading practices, taking timely action is essential. For primary communication, feel free to contact the Gross Law Firm at their office:

The Gross Law Firm
15 West 38th Street, 12th Floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

For additional information, detailed participation instructions, and the opportunity to register, please visit
The Gross Law Firm's announcement page here. This case represents a critical juncture for shareholders of Replimune Group, and ensuring your voice is heard is more important now than ever.